Phase One, Open Label, Homologous Reinfection with Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) or Dengue-3-Virus-Live Virus Human Challenge (DENV-3-LVHC) Virus Strains
Read moreA Phase 1/2, Randomized, Dose-finding/Dose-confirmation Study to Evaluate the Reactogenicity, Safety and Immuno genicity of mRNA-based Multivalent Season Influenza Vaccine Candidates
Read moreA Phase-1, Double-blind, Randomized, Placebo-controlled Study to Assess the Antiviral Activity and Safety of AT-752 in a Dengue Human Challenge Model
Read moreA Phase-1, Double-blind, Randomized, Placebo-controlled Study to Assess the Antiviral Activity and Safety of AT-752 in a Dengue Human Challenge Model
Read moreA Phase-1, Placebo-controlled, Randomized, Observer-blind, Dose-finding Study to Evaluate the Safety, Tolerability, and Immunogenicity of Self-amplifying RNA Vaccine Preparations against Influenza in Healthy Individuals
Read moreCIVICs Influenza, SARS-CoV-2, and Other Respiratory Pathogen Screening Protocol for Future Challenge and Vaccination Studies
Read more